Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-21-058498

Options or other derivatives

  • CAO and VP of Finance acquired 38,954 shares (grant or award)
  • CAO and VP of Finance disposed of 290,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Donegan Michael C · CAO and VP of Finance

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2021-09-29 Grant or award : show line 1 in the form Restricted Stock Units +38,954 38,954 D
2021-09-29 Other disposition : show line 2 in the form Non-Qualified Stock Option (right to buy) −50,000 0 D
2021-09-29 Other disposition : show line 3 in the form Non-Qualified Stock Option (right to buy) −100,000 0 D
2021-09-29 Other disposition : show line 4 in the form Non-Qualified Stock Option (right to buy) −40,000 0 D
2021-09-29 Other disposition : show line 5 in the form Non-Qualified Stock Option (right to buy) −100,000 0 D
Loading xslF345X03/doc4.xml…